| Literature DB >> 25723190 |
Matthew W Rotz, Kayla S B Culver, Giacomo Parigi1, Keith W MacRenaris, Claudio Luchinat1, Teri W Odom, Thomas J Meade.
Abstract
Gadolinium(III) nanoconjugate contrast agents (CAs) have distinct advantages over their small-molecule counterparts in magnetic resonance imaging. In addition to increased Gd(III) payload, a significant improvement in proton relaxation efficiency, or relaxivity (r1), is often observed. In this work, we describe the synthesis and characterization of a nanoconjugate CA created by covalent attachment of Gd(III) to thiolated DNA (Gd(III)-DNA), followed by surface conjugation onto gold nanostars (DNA-Gd@stars). These conjugates exhibit remarkable r1 with values up to 98 mM(-1) s(-1). Additionally, DNA-Gd@stars show efficient Gd(III) delivery and biocompatibility in vitro and generate significant contrast enhancement when imaged at 7 T. Using nuclear magnetic relaxation dispersion analysis, we attribute the high performance of the DNA-Gd@stars to an increased contribution of second-sphere relaxivity compared to that of spherical CA equivalents (DNA-Gd@spheres). Importantly, the surface of the gold nanostar contains Gd(III)-DNA in regions of positive, negative, and neutral curvature. We hypothesize that the proton relaxation enhancement observed results from the presence of a unique hydrophilic environment produced by Gd(III)-DNA in these regions, which allows second-sphere water molecules to remain adjacent to Gd(III) ions for up to 10 times longer than diffusion. These results establish that particle shape and second-sphere relaxivity are important considerations in the design of Gd(III) nanoconjugate CAs.Entities:
Keywords: contrast agent; gadolinium; magnetic resonance; nanostar; nuclear magnetic resonance dispersion; relaxivity; second-sphere
Mesh:
Substances:
Year: 2015 PMID: 25723190 PMCID: PMC4489565 DOI: 10.1021/nn5070953
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881